Pharmaceutical

Oncolytic Virus for Human Papillomavirus Associated Can...

Oncolytic Virus for Human Papillomavirus Associated Cancer, Human Papillomavirus...

ABBV-101 by AbbVie for Relapsed Chronic Lymphocytic Leu...

ABBV-101 is under clinical development by AbbVie and currently in Phase I for Re...

CC-95775 by Bristol-Myers Squibb for Solid Tumor: Likel...

CC-95775 is under clinical development by Bristol-Myers Squibb and currently in ...

MesoCancerVac by Amphera for Metastatic Pancreatic Canc...

MesoCancerVac is under clinical development by Amphera and currently in Phase I ...

AC-0676 by Accutar Biotechnology for Follicular Lymphom...

AC-0676 is under clinical development by Accutar Biotechnology and currently in ...

Selinexor by Karyopharm Therapeutics for Osteosarcoma: ...

Selinexor is under clinical development by Karyopharm Therapeutics and currently...

ORIN-1001 by Shanghai Fosun Pharmaceutical (Group) for ...

ORIN-1001 is under clinical development by Shanghai Fosun Pharmaceutical (Group)...

CJ-15314 by HK inno.N for Atopic Dermatitis (Atopic Ecz...

CJ-15314 is under clinical development by HK inno.N and currently in Phase I for...

AMG-305 by Amgen for Breast Cancer: Likelihood of Approval

AMG-305 is under clinical development by Amgen and currently in Phase I for Brea...

Opinion: Listen: Is the medical system ready for Alzhei...

Leqembi is a game-changer for Alzheimer's. But the health care system needs to c...

Opinion: Sen. Bill Cassidy: Smart, practical ways to lo...

The physician turned senator on how to balance the need to lower drug prices whi...

STAT+: Novo Nordisk bought prescribers over 450,000 mea...

Novo Nordisk bought 457,222 meals to educate doctors about its drugs like Ozempi...

STAT+: FDA approves first Alzheimer’s therapy shown to ...

The FDA has granted full approval to the first therapy for Alzheimer’s disease c...

STAT+: Generic group sues Minnesota over a drug pricing...

The generic trade group argued the “draconian regulations” come at a time when t...

Why depression after traumatic brain injury is distinct...

Depression after traumatic brain injury is distinct, a new study finds, and ther...

STAT+: Pharmalittle: Next big hope for Alzheimer’s migh...

Critics say any positive impact from the Alzheimer's drug Leqembi will not benef...